These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Editorial overview: from Vioxx to Luckenbach: drug discovery at a crossroads. Williams M Curr Opin Investig Drugs; 2005 Jan; 6(1):17-20. PubMed ID: 15675599 [No Abstract] [Full Text] [Related]
10. Corrigendum to 'Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart' [Eur J Heart Fail] 2015 August;17(8): 760-763. doi:10.1002/ejhf.315. Eur J Heart Fail; 2015 Dec; 17(12):1317. PubMed ID: 26647216 [No Abstract] [Full Text] [Related]
11. Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart. Senni M; Gavazzi A; Gheorghiade M; Butler J Eur J Heart Fail; 2015 Aug; 17(8):760-3. PubMed ID: 26179815 [No Abstract] [Full Text] [Related]
12. Patents in Nanobiotechnology: A Cross Jurisdictional Approach. Manchikanti P; Uppala S; Bonta RK Recent Pat Biotechnol; 2017; 11(1):52-70. PubMed ID: 27881055 [TBL] [Abstract][Full Text] [Related]
13. Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. Burns A; Ow H; Wiesner U Chem Soc Rev; 2006 Nov; 35(11):1028-42. PubMed ID: 17057833 [TBL] [Abstract][Full Text] [Related]
14. Editorial: Biochips and nanobiotechnology. Park HG; Lee SY Biotechnol J; 2009 Nov; 4(11):1502-3. PubMed ID: 19918783 [No Abstract] [Full Text] [Related]
15. Taking a Concept to Commercialization: Designing Relevant Tests to Address Safety. Ferrara LA Spine (Phila Pa 1976); 2016 Apr; 41 Suppl 7():S8-9. PubMed ID: 27015077 [TBL] [Abstract][Full Text] [Related]
16. Editorial: Methods in nanobiotechnology. Gentile P; Tonda-Turo C Front Bioeng Biotechnol; 2022; 10():1067952. PubMed ID: 36406212 [No Abstract] [Full Text] [Related]
17. Biomarkers and proof of concept. Ferber G Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():35-40. PubMed ID: 12575486 [TBL] [Abstract][Full Text] [Related]
18. Chronic care at the crossroads: Exploring solutions for chronic care management. The "crossroads" and beyond. Nash DB Dis Manag; 2007; 10 Suppl 2():S1-2. PubMed ID: 18171138 [No Abstract] [Full Text] [Related]
19. Engineered cell culture substrates for axon guidance studies: moving beyond proof of concept. Roy J; Kennedy TE; Costantino S Lab Chip; 2013 Feb; 13(4):498-508. PubMed ID: 23288417 [TBL] [Abstract][Full Text] [Related]